LIFNANO THERAPEUTICS
LIFNano Therapeutics was founded in 2013 as a spin-out from the University of Cambridge, progressing to a clinical stage Nano-Bio-Med company specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor (LIF)..
LIFNANO THERAPEUTICS
Industry:
Biotechnology Medical Nanotechnology Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.lifnano.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.26 M USD
Technology used in webpage:
Viewport Meta Google Font API Content Delivery Network Euro Typekit LocalBusiness Schema Squarespace
Similar Organizations
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Employees Featured
Founder
Investors List
Innovate UK
Innovate UK investment in Grant - LIFNano Therapeutics
Pitch@Palace
Pitch@Palace investment in Non Equity Assistance - LIFNano Therapeutics
Newest Events participated
Participated in Pitch@Palace 5.0
on 2016-03-07 as exhibitor
Official Site Inspections
http://www.lifnano.com
- Host name: 172.67.131.70
- IP address: 172.67.131.70
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "LIFNano Therapeutics"
LIFNano
LIFNano Therapeutics is a spin-out from the University of Cambridge, UK, progressing to a clinical stage NanoBioMedicine company specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor (LIF).See details»
LIFNano Therapeutics - Crunchbase Company Profile & Funding
LIFNano Therapeutics was founded in 2013 as a spin-out from the University of Cambridge, progressing to a clinical stage Nano-Bio-Med company specifically focused on targeted …See details»
Team — LIFNano
LIFNano behaves as an artificial stem cell with powerful properties for Brain Health. These properties are captured using nanotechnology with LIFNano a world leader in the new era of …See details»
LIFNano Therapeutics Company Profile 2024: Valuation, Funding ...
Manufacturer and developer of novel therapeutics designed to treat multiple sclerosis and other neurodegenerative diseases.See details»
LIFNano Therapeutics - Craft
See insights on LIFNano Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
LIFNano Therapeutics - LinkedIn
It is known that LIF (Leukaemia Inhibitory Factor) is a protein that can enable the repair of damaged neurons, and has promised the possibility of treatment for Multiple Sclerosis and other...See details»
LIFNano Therapeutics - VentureRadar
Website: https://www.lifnano.com/ LIF, short for Leukaemia Inhibitory Factor, is a small blood-borne protein functioning to repair damaged tissues throughout the body.See details»
LIFNano Therapeutics - Cambridge Judge Business School
LIFNano Therapeutics has invented and patented a new approach to treat multiple sclerosis (MS) using nano-technology. Cambridge Social Ventures believes that this medical innovation has …See details»
CEO, Founder & President at LIFNano Therapeutics - The Org
Su Metcalfe is the CEO, Founder, and President of LIFNano Therapeutics. Prior to this, they were the founder president and CSO of LIFNanoRx Ltd.See details»
About — LIFNano
LIFNano Therapeutics is a spin-out from the University of Cambridge, UK, progressing to a clinical stage NanoBioMedicine company specifically focused on targeted delivery of the biologic, …See details»
LIFNanoRx - Cambridge Judge Business School
LIFNanoRx is a nano-bio-med company focused on treatment of Multiple Sclerosis (MS), a disabling incurable auto-immune inflammatory disease of the central nervous system (CNS) …See details»
Investor Relations — LIFNano
LIFNanoRx Ltd is the world's first Synthetic Stem Cell Company, capturing the power of stem cells inside tiny nanoparticles of FDA-approved gel - "LIFNano™" - and so providing a low cost, …See details»
Frontiers | Multiple Sclerosis: LIFNano-CD4 for Trojan Horse …
Apr 6, 2021 · Nano-formulation of LIF (LIFNano) using FDA-approved PLGA captures LIF's compound therapeutic properties, increasing potency 1,000-fold when targeted to CD4 …See details»
LIFNanoRx - Drug Targets, Indications, Patents - Synapse - Patsnap
Understand key drug designations in just a few clicks with Synapse. LIFNanoRx, Initially developed by LIFNano Rx Ltd., Now, its global highest R&D status is Pending, Therapeutic …See details»
Multiple Sclerosis: LIFNano-CD4 for Trojan Horse Delivery of the …
Apr 7, 2021 · Nano-formulation of LIF (LIFNano) using FDA-approved PLGA captures LIF's compound therapeutic properties, increasing potency 1,000-fold when targeted to CD4 …See details»
Nanoparticles Carry Neuroprotective LIF Protein to Brain: MS …
May 20, 2021 · LIF, a protein with anti-inflammatory and neuroprotective properties, can be successfully delivered to immune cells in the brain using a nanoparticle formulation, and …See details»
Multiple Sclerosis: LIFNano-CD4 for Trojan Horse ... - ResearchGate
Apr 7, 2021 · Nano-formulation of LIF (LIFNano) using FDA-approved PLGA captures LIF's compound therapeutic properties, increasing potency 1,000-fold when targeted to CD4 …See details»
hLIFNano-CD4: Single Ascending Dose Preclinical Toxicity Trial: …
LIF is a vital stem cell growth factor active throughout life—and essential for health of the centr... ... we asked, is LIFNano-CD4 safe? Here a single ascending dose (SAD) preclinical trial in...See details»
Multiple Sclerosis: LIFNano-CD4 for Trojan Horse Delivery of the …
Apr 7, 2021 · Nano-formulation of LIF (LIFNano) using FDA-approved PLGA captures LIF's compound therapeutic properties, increasing potency 1,000-fold when targeted to CD4 …See details»
LIFNano therapy swiftly reverses paralysis in the EAE model …
LIFNano therapy swiftly reverses paralysis in the EAE model (adapted from reference [177]). Mice were immunized against myelin protein, which led to paralysis of the legs and tail region on the...See details»